Coronavirus Clinical Trial
Official title:
Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19
The current health crisis at COVID-19 is forcing us to profoundly rethink our social
organizations, especially towards our most fragile seniors. Prohibitions on visits to Nursing
Homes and care services, although essential to control the epidemic, are also becoming a
major source of social isolation and loneliness for these fragile populations. The only
source of residual social ties during a period of confinement remains dematerialised
communication via the various existing communication channels (in particular telephone calls
or video telephony).
As soon as the COVID-19 crisis began and the first visiting restrictions were imposed on
patients in the geriatric department of the Angers Univesity Hospital and the Retirement Home
/ long-term care unit, acute care geriatric unit of Angers offered patients and residents the
opportunity to organize communication with their relatives via videophone calls. Initial
feedback from the field shows us that, contrary to our intuition, patients and residents are
not necessarily asking for communication to the outside world and, when they are, the
preferred channel is not necessarily video telephony but often a simple phone call with
relatives. Even though the vast majority of projects aimed at setting up communication aids
for the elderly now rely on videophonic support, these initial observations in everyday care
situations raise questions about the directions taken in this area. Also, the investigators
ask themselves the following question: in the absence of a physical meeting, what is the
preferred means of communication for elderly people in isolation in hospital or in Retirement
Home? This study will make it possible to propose the most appropriate solutions for breaking
isolation for the hospitalized or institutionalized geriatric population in order to limit as
much as possible the increase in social isolation imposed by restrictions on movement during
epidemics.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05065827 -
Lung Ultrasound Findings in Patients With COVID-19 in a UK ED
|
||
Recruiting |
NCT05359770 -
Association of Inspiratory Muscle Training With HD-tDCS for Assistance to Patients With Long Covid-19
|
N/A | |
Completed |
NCT04515147 -
A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19
|
Phase 2 | |
Not yet recruiting |
NCT06025812 -
Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)
|
N/A | |
Recruiting |
NCT05289115 -
Protocol for Assistance to Patients With Long Covid-19 Undergoing Treatment With HD-tDCS
|
N/A | |
Completed |
NCT04779138 -
Increasing Vaccine Uptake in Underresourced Public Housing Areas
|
N/A | |
Completed |
NCT04953078 -
A Study to Evaluate Safety, Tolerability, and Reactogenicity of an RBD-Fc-based Vaccine to Prevent COVID-19
|
Phase 1 | |
Not yet recruiting |
NCT05868239 -
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
|
N/A | |
Completed |
NCT04690413 -
NOWDx Test for the Detection of Antibodies to COVID-19
|
N/A | |
Completed |
NCT04818164 -
Prone Position Improves End-Expiratory Lung Volumes in COVID-19 Acute Respiratory Distress Syndrome
|
||
Terminated |
NCT04530448 -
Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization
|
Phase 4 | |
Completed |
NCT04572399 -
UVA Light Device to Treat COVID-19
|
N/A | |
Recruiting |
NCT04610567 -
Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19)
|
Phase 1/Phase 2 | |
Recruiting |
NCT04772170 -
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
|
||
Recruiting |
NCT04581954 -
Inflammatory Signal Inhibitors for COVID-19 (MATIS)
|
Phase 1/Phase 2 | |
Completed |
NCT04405934 -
COG-UK Project Hospital-Onset COVID-19 Infections Study
|
N/A | |
Enrolling by invitation |
NCT04484025 -
SPI-1005 Treatment in Moderate COVID-19 Patients
|
Phase 2 | |
Completed |
NCT05572840 -
Wear Your Mask, Wash Your Hands, Don't Get COVID-19
|
N/A | |
Withdrawn |
NCT04838847 -
A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19
|
Phase 3 | |
Terminated |
NCT04371978 -
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
|
Phase 3 |